West Pharmaceutical Services WST Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $3.07B+6.3% | $2.89B-1.9% | $2.95B+2.2% | $2.89B+2.0% | ||
| $1.97B+4.0% | $1.89B+4.1% | $1.82B+4.0% | $1.75B+5.7% | ||
| $1.1B+10.6% | $998.5M-11.6% | $1.13B-0.6% | $1.14B-3.4% | ||
| 35.9%+1.4pp | 34.5%-3.8pp | 38.3%-1.1pp | 39.4%-2.2pp | ||
| $74.3M+7.5% | $69.1M+1.0% | $68.4M+16.9% | $58.5M+10.8% | ||
| $393.6M+16.3% | $338.5M-4.2% | $353.4M+11.5% | $316.9M-12.7% | ||
| $584.9M+2.6% | $569.9M-15.7% | $676M-7.9% | $734M-2.4% | ||
| 19%-0.7pp | 19.7%-3.2pp | 22.9%-2.5pp | 25.4%-1.1pp | ||
| —— | —— | $9M+13.9% | $7.9M-3.7% | ||
| -$1M0.0% | -$1M— | —— | -$53.1M-1,497% | ||
| $600.9M+2.6% | $585.5M-16.1% | $698M+2.7% | $679.9M-9.2% | ||
| $121.6M+13.1% | $107.5M-12.1% | $122.3M+6.6% | $114.7M+7.0% | ||
| $493.7M+0.2% | $492.7M-17.0% | $593.4M+1.3% | $585.9M-11.5% | ||
| 16.1%-1.0pp | 17%-3.1pp | 20.1%-0.2pp | 20.3%-3.1pp | ||
| $6.79+1.5% | $6.69-15.1% | $7.88+1.9% | $7.73-10.7% | ||
| $755.7M+4.3% | $724.4M-10.5% | $809.7M-4.9% | $851.1M-2.1% | ||
| 24.6%-0.5pp | 25%-2.4pp | 27.4%-2.0pp | 29.5%-1.2pp | ||
| $584.9M+2.6% | $569.9M-15.7% | $676M-7.9% | $734M-2.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is West Pharmaceutical Services's revenue?
- West Pharmaceutical Services (WST) generated $3.2B in revenue over the trailing twelve months, up 11.2% year over year.
- Is West Pharmaceutical Services profitable?
- West Pharmaceutical Services reported $542.7M in net income over the trailing twelve months, a 16.8% net margin.
- What are West Pharmaceutical Services's profit margins?
- Gross margin is 36.3% and operating margin is 20.3%, with a 16.8% net margin.
- What is West Pharmaceutical Services's earnings per share?
- West Pharmaceutical Services's diluted EPS over the trailing twelve months is $7.48.
- Where does West Pharmaceutical Services's income statement data come from?
- Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
